Fingerprint
Dive into the research topics of 'Neoadjuvant Docetaxel and Capecitabine in Patients With High Risk Prostate Cancer'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Neoadjuvant Docetaxel and Capecitabine in Patients With High Risk Prostate Cancer
Judah Friedman*, Rodney L. Dunn, David Wood, Ulka Vaishampayan, Angela Wu, Deborah Bradley, James Montie, Fazlul H. Sarkar, Rajal B. Shah, Maha Hussain
*Corresponding author for this work
Research output: Contribution to journal › Article › peer-review
30
Scopus
citations